Nse Nifty

Silver Touch Tech up 7%, hits all-time high; here's what's boosting rally

Silver Touch Technologies shares were in demand after the company was selected as the Digital Transformation Partner for the Indian Navy under the IPADSV2 initiative

Mangalam Drugs & Organics shares hits 5% upper circuit; here's why

On Monday, according to the National Stock Exchange (NSE) bulk deal data, Kedia Securities, headed by Vijay Kedia, purchased 1,37,794 shares at ₹24.15 per share

Shriram Finance shares rise 2% on ratings upgrade; up 13% in a month

The buying on the counter came after Care Ratings upgraded its stance on the company's non-convertible debentures and subordinated debt

New Year picks 2026: Motilal Oswal Wealth bets on Airtel, SBI, Eternal

New Year picks 2026: Motilal Oswal Wealth Management has picked SBI, Airtel, Biocon, Eternal and others for the upcoming year; check details here

Skipper newly rated 'Buy' at Systematix; 17% upside potential seen

Skipper is among the top 10 transmission tower manufacturers globally and has built a strong cost advantage through high backward integration, sourcing nearly 90 per cent of its raw materials in-house

Market outlook 2026: Earnings, Budget, FII flow, trade deal to drive stocks

Market outlook 2026: Looking ahead, Akshat Garg, head of research & product at Choice Wealth, believes calendar year 2026 is likely to be a stock-picker's market

Ravelcare zooms 13% after NAV Capital VCC, Navbharat Investment buys stake

According to the BSE bulk deal data, NAV Capital VCC - NAV Capital Emerging Star Fund acquired 35,000 equity shares, while Navbharat Investment Opportunities Fund bought 50,000 shares

What does Coforge's Encora acquisition mean for investors? Analysts weigh

Brokerages see the acquisition as aligned with Coforge's stated ambition to shift more deeply into higher-value, AI-driven engineering services

Timex Group India slips 10% as promoter launches 4.47% stake sale via OFS

Timex Group Luxury Watches BV, the promoter of Timex Group India, has announced an OFS of up to 45,09,250 shares (4.47 per cent stake) in Timex Group India

Axis Bank's growth improving; NIMs to bottom in Q4FY26/Q1: Motilal Oswal

The brokerage has reiterated its 'Neutral' rating on the stock with a target price of ₹1,300 after its interaction with the top management team of Axis Bank

2026 investment strategy: PSU banks, IT 'cheap'; defence stocks 'expensive'

Analysts think financials, metals, and IT sectors are trading at 'relatively' better values and may offer suitable entry points at current levels

RVNL, IRFC, IRCTC: Railway stocks rally up to 12% in trade; here's why

Railway stocks surged after the Indian Railways implemented a revised passenger fare structure which marks the second fare hike in the 2025-26 financial year

Ashok Leyland set to ride CV upcycle; Choice hikes target, retains 'Buy'

The brokerage believes Ashok Leyland is poised to be a major beneficiary of India's ongoing commercial vehicle (CV) upcycle, helped by firming domestic demand, rising exports

Motilal Oswal's top picks: TCS, SBI, Biocon, Dalmia Bharat & others

Motilal Oswal bets on TCS, SBI, Biocon, Dalmia Bharat, Astra Microwave Products and others; here's why

NBCC shares rise 5% in trade; what is driving investors' interest?

NBCC gained after it inked an MoU with the Board of Mumbai Port Authority and entered international real estate space through its arm

Castrol India up 4% after Motion JVCo, Stonepeak, & CPPIB makes open offer

The buying on the counter came after Motion JVCo Limited, together with Stonepeak Motion Holdco Limited and CPP Investment announced an open offer to acquire up to 26 per cent equity of Castrol India

Motilal Oswal sees strong growth visibility for Brigade Ent; retains 'Buy'

Motilal Oswal believes Brigade Enterprises is now entering a new phase of geographic and asset-class expansion, led by fresh residential, commercial and hospitality bets beyond its Bengaluru core

Ajanta Pharma to generate healthy margins from Biocon deal: PL Capital

According to PL Capital, Ajanta Pharma's strong franchise will aid in garnering a higher market share for semaglutide

Manappuram Finance, Indus Towers among technical picks suggested by analyst

Kunal Kamble of Bonanza recommends buying Manappuram Finance, Indus Towers and Nuvama Wealth; here's why

PL Capital hikes Adani Ports target on NQXT acquisition; retains 'Buy'

PL Capital maintained 'Buy' as it builds in stronger volumes and margins following the acquisition of North Queensland Export Terminal (NQXT)